MedPath

Time-course of Mitochondrial Biogenic Gene and Protein Expression in Exercised Human Skeletal Muscle

Not Applicable
Conditions
Mitochondrial Biogenesis
Registration Number
NCT03975777
Lead Sponsor
Brendon Gurd, PhD
Brief Summary

This study examines the impact of exercise intensity on the 12-hour time-course of mitochondrial biogenic gene and protein expression in human skeletal muscle. Briefly, participants will perform two experimental sessions involving an acute bout of work-matched low- or high-intensity interval cycling exercise in a randomized crossover fashion, two weeks apart. Skeletal muscle biopsies will be obtained from the vastus lateralis (3 from each leg) before and 1, 3, 6, 9, and 12 hours post-exercise. Changes in the expression of various transcription factors and mitochondrial proteins will be examined at the mRNA and protein level to determine the time-course of changes in these factors differs between exercise protocols of different intensities.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
10
Inclusion Criteria
  • recreationally active (no more than three hours of structured weekly physical activity)
  • not currently involved in a systematic training program for improving cardiorespiratory fitness, muscular strength, and/or sport-specific skills
  • body mass index < 30 kg/m2
Exclusion Criteria
  • presence of cardiometabolic disease
  • taking regular prescription medication for the treatment of cardiometabolic disease
  • current cigarette smoker

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in peroxisome proliferator activated receptor (PPAR) gamma co-activator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA) expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

PGC-1α gene expression (indirect indicator of PGC-1α activity). Transcriptional co-activator involved in the control of mitochondrial biogenesis.

Secondary Outcome Measures
NameTimeMethod
Change in PGC-1α protein contentbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

PGC-1α protein content

Change in Nrf2 protein contentbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

Nrf2 protein content

Change in LRP130 protein contentbefore exercise and 1, 3, 6, 9, and 12 hours post-exercise

LRP130 protein content

Change in COXI mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

COXI gene expression. Mitochondrial encoded subunit of the electron transport chain complex IV (COX)

Change in NRF-2 mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exercise

NRF-2 gene expression. Transcription factor involved in the control of mitochondrial biogenesis.

Change in nuclear factor-erythroid 2 like 2 (Nrf2) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

Nrf2 gene expression (indirect indicator of Nrf2 activity). Transcription factor involved in the control of mitochondrial biogenesis.

Change in NRF-1 protein contentbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

NRF-1 protein content

Change in ND4 mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

ND4 gene expression. Mitochondrial encoded subunit of the electron transport chain complex 1 (NADH dehydrogenase).

Change in PPAR-beta mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

PPAR-beta gene expression (indirect indicator of PPAR-beta activity). Transcription factor involved in the control of mitochondrial biogenesis.

Change in estrogen related receptor (ERR)-gamma mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exercise

ERR-gamma gene expression. Transcription factor involved in the control of mitochondrial biogenesis.

Change in leucine-rich pentatricopeptide repeat containing protein 130 (LRP130) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

LRP130 gene expression. Transcriptional co-activator and RNA-binding protein involved in the transcriptional control and stabilization of mitochondrial mRNAs

Change in mitochondrial transcription factor A (TFAM) mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exercise

TFAM gene expression. Transcription factor controlling the expression of mitochondrial-encoded genes.

Change in TFAM protein contentbefore exercise and 1, 3, 6, 9, and 12 hours post-exercise

TFAM protein content

Change in p53 mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

p53 gene expression. Transcription factor involved in the control of mitochondrial biogenesis.

Change in cytochrome c oxidase subunit 4 (COXIV) mRNA expression.before exercise to 1, 3, 6, 9, and 12 hours post-exercise

COXIV gene expression. Nuclear encoded subunit of the electron transport chain complex 4 (COX)

Change in COXII mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

COXII gene expression.Mitochondrial encoded subunit of the electron transport chain complex IV (COX).

Change in nicotinamide adenine dinucleotide (NADH) subunit 1 (ND1) mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exercise

ND1 gene expression. Mitochondrial encoded subunit of the electron transport chain complex 1 (NADH dehydrogenase)

Change in citrate synthase (CS) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

CS gene expression. The first rate limiting enzyme of the Kreb's cycle.

Change in nuclear respiratory factor-1 (NRF-1) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

NRF-1 gene expression. Transcription factor involved in the control of mitochondrial biogenesis.

Change in mitochondrial transcription factor B1 (TFB1M) mRNA expressionbefore exercise to 1, 3, 6, 9, and 12 hours post-exercise

TFB1M gene expression. Transcription factor controlling the expression of mitochondrial-encoded genes.

Change in mitochondrial transcription factor B2 (TFB2M) mRNA expressionbefore exercise and 1, 3, 6, 9, and 12 hours post-exercise

TFB2M gene expression. Transcription factor controlling the expression of mitochondrial-encoded genes.

Trial Locations

Locations (1)

School of Kinesiology and Health Studies

🇨🇦

Kingston, Ontario, Canada

School of Kinesiology and Health Studies
🇨🇦Kingston, Ontario, Canada
Hashim Islam, MSc
Contact
4037954125
16mhi@queensu.ca

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.